Skip to main content
OpenTrials

Clinical trial condition

Hepatorenal Syndrome

Explore clinical trials studying Hepatorenal Syndrome. Study availability and eligibility vary by location and protocol.

20 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Hepatorenal Syndrome trial results

Completed

Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1

NCT02770716

Conditions
Digestive System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner Good Samaritan Medical Center Phoenix, Arizona, United States
  • Mayo Clinic - AZ Phoenix, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
View all 64 locations
View Trial Details
Completed

A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin

NCT01143246

Conditions
Alcohol-Induced Disorders, Alcohol-Related Disorders, Ascites, +18 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner Good Samaritan Medical Center/Liver Disease Center Phoenix, Arizona, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of Arizona Medical Center South Campus Tucson, Arizona, United States
View all 73 locations
View Trial Details
Completed

Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1

NCT00089570

Conditions
Digestive System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +6 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • University of Arizona College of Medicine Tucson, Arizona, United States
  • UCLA School of Medicine Los Angeles, California, United States
  • UC Davis Medical Center Sacramento, California, United States
View all 37 locations
View Trial Details
Completed

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

NCT01436500

Conditions
Digestive System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +6 more
Locations
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • UCSD, Hillcrest Medical Center Hospital La Jolla, California, United States
  • UCSF (University of California-San Francisco) San Francisco, California, United States
  • Emory University Hospital Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome

NCT06256432

Conditions
Acute Kidney Injury, Ascites Hepatic, Digestive System Diseases, +13 more
Locations
  • Aster CMI Hospital Bangalore, Karnataka, India
  • Sir HN Reliance Hospital Foundation Mumbai, Maharashtra, India
  • All India Institute of Medical Sciences New Delhi, National Capital Territory of Delhi, India
  • Asian Institute of Gastroenterology (AIG) Hyderabad, Telangana, India
View Trial Details

Related conditions